Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe phrase "best deals for Mounjaro" is everywhere online, but it points at the wrong question. Mounjaro (tirzepatide) is a prescription-only medicine: the only legal way to obtain it in the UK is through a qualified prescriber following a clinical assessment, which means the variables worth comparing are service quality, safety infrastructure and what your price actually covers — not which site offers a discount code. Here's what the research actually shows about how to find legitimate, good-value access to tirzepatide in the UK.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people searching for deals on Mounjaro are doing exactly what they'd do before buying anything else online, looking for the lowest price. That instinct makes perfect sense for a book or a pair of trainers. For a prescription medicine it identifies the wrong variable entirely.
Mounjaro is a Black Triangle (▼) prescription-only medicine, subject to additional MHRA monitoring. A prescriber must assess your medical history, current medications, BMI and any relevant conditions before issuing a prescription, that clinical step is not optional formality, it is the mechanism that keeps the medicine safe for you specifically. Any listing that sidesteps it is not offering a deal; it is selling something unlicensed for the purpose.
The MHRA has been explicit on this. Following large-scale enforcement through 2024 and 2025 (including the raid of a Northampton site manufacturing fake tirzepatide pens) the agency advises the public to report suspect sellers via the Yellow Card scheme and to verify every online pharmacy on the GPhC register before ordering. That verification takes about thirty seconds and tells you everything a price comparison cannot.
So when someone finds a listing that looks significantly cheaper than the typical UK private range, the first question is not "how do I order", it is "what has been left out?"
Until September 2025, Mounjaro's UK list price was relatively stable. Eli Lilly then raised it substantially (the highest-dose pen's list price rose from around £122 to around £330) and the private market followed. As widely reported at the time, typical monthly private costs since that change range from roughly £149 at the lower doses to around £375 at the top of the schedule, varying by provider and dose.
That context matters for two reasons. First, if you see a current price significantly below £149 for any dose from an unfamiliar source, that gap needs explaining. Second, it is worth understanding what a legitimate provider's price actually covers. For an honest breakdown of what private Mounjaro costs include (and what they often exclude) the Mounjaro cost page goes through the components in detail.
At nume (at a GPhC-registered pharmacy (registration 9012878)) one price covers the free consultation, the prescriber's review, the prescription, the medicine itself and free next-working-day tracked delivery. There are no subscription fees and no auto-renewals; every repeat order is reviewed clinically before it is approved. That structure is deliberately transparent, not because it is the cheapest option on the market, but because hidden fees are the other way a low headline price misleads people.
If you want to make a genuinely informed comparison, here are the questions that matter more than the headline price.
Is the pharmacy GPhC-registered? Every legitimate online pharmacy dispensing prescription medicines in the UK must be listed on the GPhC register, you can search at pharmacyregulation.org/registers. Not on the register: walk away.
Who reviews your consultation, a prescriber or software? NICE and NHS guidance on weight-management medicines expects clinical assessment, not an automated questionnaire that rubber-stamps any answer. At nume, a GPhC-registered Independent Prescriber reads every consultation the same day it is submitted.
What safety checks are in place? Photo-ID verification, live weight confirmation, GP notification and evidence-checking for dose increases are not bureaucratic friction, they are what keeps treatment safe. Providers skipping these steps are the ones most likely to be cutting costs in ways that matter.
What happens after you order? Ongoing clinical support and access to prescribers between orders is part of responsible prescribing for a medicine like this. Aftercare is also where legitimate providers earn the price difference.
Knowing where to inject, when to take the pen and how to store it properly also affects how well treatment works, the guide to injection sites and the timing guide cover both in practical detail. What you eat alongside treatment matters too; food choices on Mounjaro can affect tolerability and results significantly.
One thing worth knowing concretely: when a Mounjaro order is dispatched through nume, it arrives the next working day via DPD, in plain unbranded packaging, with a tracking link sent to your phone. The pen itself is the original Eli Lilly KwikPen, sourced through the licensed UK supply chain. What you open is what was prescribed, no question about provenance, no ambiguity about storage conditions in transit.
That is not a luxury detail. The counterfeit pens the MHRA has seized have included insulin in place of tirzepatide, a substitution that has caused hospitalisations. The packaging looking right is not enough; the supply chain behind it is what matters.
Mounjaro is a once-weekly subcutaneous injection that works as a dual GIP and GLP-1 receptor agonist, the only licensed medicine of its kind in the UK for weight management. NICE's appraisal of tirzepatide (TA1026) assessed a substantial body of clinical evidence before recommending it, and the Mounjaro overview page covers the full picture of how it works, what the trials showed and who it is licensed for. The comparison with other GLP-1 options, including how tirzepatide performed against semaglutide in the SURMOUNT-5 head-to-head trial, is covered on the comparison page for those weighing up options.
If you think you meet the eligibility criteria and want a prescriber to assess whether Mounjaro is right for you, the straightforward next step is to check your eligibility with a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.